China Pharma Holdings (CPHI) Inventory (2010 - 2026)

China Pharma Holdings' Inventory history runs 17 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• Quarterly Inventory fell 45.85% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (down 45.85% YoY) and the FY2025 annual result came in at $1.6 million, down 28.45% from the prior year.
• Inventory was $1.5 million for Q1 2026 at China Pharma Holdings, down from $1.6 million in the prior quarter.
• Across five years, Inventory topped out at $3.9 million in Q2 2023 and bottomed at $1.5 million in Q1 2026.
• A 5-year average of $2.9 million and a median of $2.9 million in 2022 frame the typical range for Inventory.
• Annual changes were most pronounced in 2023 — Inventory surged 31.01% — and 2026, when it sank 45.85%.
• China Pharma Holdings' Inventory stood at $2.9 million in 2022, then jumped by 31.01% to $3.9 million in 2023, then tumbled by 41.32% to $2.3 million in 2024, then slipped by 28.45% to $1.6 million in 2025, then slipped by 7.58% to $1.5 million in 2026.
• Business Quant data shows CPHI's Inventory at $1.5 million in Q1 2026, $1.6 million in Q4 2025, and $1.6 million in Q3 2025.